210 related articles for article (PubMed ID: 16682430)
21. [Detection of K-ras gene mutations in DNA extracted from the plasma of patients with pancreatic cancer].
Feng D; Han T; Jiang Y; Yuan Z; Wang X; Jiang Z; Zhang S
Zhonghua Wai Ke Za Zhi; 2000 Oct; 38(10):767-70. PubMed ID: 11832160
[TBL] [Abstract][Full Text] [Related]
22. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma.
Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P
Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083
[TBL] [Abstract][Full Text] [Related]
23. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.
Tada M; Omata M; Ohto M
Gastroenterology; 1991 Jan; 100(1):233-8. PubMed ID: 1983826
[TBL] [Abstract][Full Text] [Related]
24. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
[TBL] [Abstract][Full Text] [Related]
25. Outcome of pancreatic cancer patients based on genetic lymph node staging.
Yamada T; Nakamori S; Ohzato H; Higaki N; Aoki T; Oshima S; Shiozaki K; Okami J; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Int J Oncol; 2000 Jun; 16(6):1165-71. PubMed ID: 10811991
[TBL] [Abstract][Full Text] [Related]
26. KRAS mutational analysis in ductal adenocarcinoma of the pancreas and its clinical significance.
Miglio U; Oldani A; Mezzapelle R; Veggiani C; Paganotti A; Garavoglia M; Boldorini R
Pathol Res Pract; 2014 May; 210(5):307-11. PubMed ID: 24629489
[TBL] [Abstract][Full Text] [Related]
27. [Detection of point mutation of Kirsten ras oncogene in pancreatic carcinoma by polymerase chain reaction].
Motojima K; Kohara N; Furui J; Terada M; Tsunoda T; Nagata Y; Urano K
Nihon Geka Gakkai Zasshi; 1991 Apr; 92(4):453-8. PubMed ID: 1870574
[TBL] [Abstract][Full Text] [Related]
28. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma.
Rijken AM; van Gulik TM; Polak MM; Sturm PD; Gouma DJ; Offerhaus GJ
J Surg Oncol; 1998 Jul; 68(3):187-92. PubMed ID: 9701213
[TBL] [Abstract][Full Text] [Related]
30. Molecular staging of colorectal cancer: K-ras mutation analysis of lymph nodes upstages Dukes B patients.
Thebo JS; Senagore AJ; Reinhold DS; Stapleton SR
Dis Colon Rectum; 2000 Feb; 43(2):155-9; discussion 159-62. PubMed ID: 10696887
[TBL] [Abstract][Full Text] [Related]
31. Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine.
Abou-Alfa GK; Chapman PB; Feilchenfeldt J; Brennan MF; Capanu M; Gansukh B; Jacobs G; Levin A; Neville D; Kelsen DP; O'Reilly EM
Am J Clin Oncol; 2011 Jun; 34(3):321-5. PubMed ID: 20686403
[TBL] [Abstract][Full Text] [Related]
32. Long-term survival after resection of pancreatic cancer: a single-center retrospective analysis.
Yamamoto T; Yagi S; Kinoshita H; Sakamoto Y; Okada K; Uryuhara K; Morimoto T; Kaihara S; Hosotani R
World J Gastroenterol; 2015 Jan; 21(1):262-8. PubMed ID: 25574100
[TBL] [Abstract][Full Text] [Related]
33. K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma.
Kawesha A; Ghaneh P; Andrén-Sandberg A; Ograed D; Skar R; Dawiskiba S; Evans JD; Campbell F; Lemoine N; Neoptolemos JP
Int J Cancer; 2000 Nov; 89(6):469-74. PubMed ID: 11102889
[TBL] [Abstract][Full Text] [Related]
34. ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis.
Sugio K; Ishida T; Yokoyama H; Inoue T; Sugimachi K; Sasazuki T
Cancer Res; 1992 May; 52(10):2903-6. PubMed ID: 1581907
[TBL] [Abstract][Full Text] [Related]
35. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
36. Prediction of Recurrence With KRAS Mutational Burden Using Ultrasensitive Digital Polymerase Chain Reaction of Radial Resection Margin of Resected Pancreatic Ductal Adenocarcinoma.
Kim SJ; Kim MJ; Han JS; Sung YN; An S; Lee JH; Song KB; Hwang DW; Lee SS; Cho H; Kim SC; Eshleman JR; Hong SM
Pancreas; 2019 Mar; 48(3):400-411. PubMed ID: 30747828
[TBL] [Abstract][Full Text] [Related]
37. K-ras-2 topographic genotyping of pancreatic adenocarcinoma.
Finkelstein SD; Przygodzki R; Pricolo VE; Sayegh R; Bakker A; Swalsky PA; Keller G
Arch Surg; 1994 Apr; 129(4):367-72; discussion 372-3. PubMed ID: 8154963
[TBL] [Abstract][Full Text] [Related]
38. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
Komori T; Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Mano Y; Kasugai T
Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
[TBL] [Abstract][Full Text] [Related]
39. Detection of mutated K12-ras in histologically negative lymph nodes as an indicator of poor prognosis in stage II colorectal cancer.
Belly RT; Rosenblatt JD; Steinmann M; Toner J; Sun J; Shehadi J; Peacock JL; Raubertas RF; Jani N; Ryan CK
Clin Colorectal Cancer; 2001 Aug; 1(2):110-6. PubMed ID: 12445369
[TBL] [Abstract][Full Text] [Related]
40. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
